Wang Ying, Zhan Yonghua, Liu Changhu, Zhan Wenhua
Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 710071, China.
Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Curr Med Chem. 2023;30(17):1945-1962. doi: 10.2174/0929867329666220819122205.
As an important determinant in drug discovery, the accurate analysis and acquisition of pharmacokinetic parameters are very important for the clinical application of drugs. At present, the research and development of new drugs mainly obtain their pharmacokinetic parameters through data analysis, physiological model construction and other methods, but the results are often quite different from the actual situation, needing more manpower and material resources.
We mainly discuss the application of machine learning technology in the prediction of pharmacokinetic parameters, which are mainly related to the quantitative study of drug absorption, distribution, metabolism and excretion in the human body, such as bioavailability, clearance, apparent volume of distribution and so on.
This paper first introduces the pharmacokinetic parameters, the relationship between the quantitative structure-activity relationship model and machine learning, then discusses the application of machine learning technology in different prediction models, and finally discusses the limitations, prospects and future development of the machine learning model in predicting pharmacokinetic parameters.
Unlike traditional pharmacokinetic analysis, machine learning technology can use computers and algorithms to speed up the acquisition of pharmacokinetic parameters to varying degrees. It provides a new idea to speed up and shorten the cycle of drug development, and has been successfully applied in drug design and development.
The use of machine learning technology has great potential in predicting pharmacokinetic parameters. It also provides more choices and opportunities for the design and development of clinical drugs in the future.
作为药物研发中的一个重要决定因素,药代动力学参数的准确分析与获取对于药物的临床应用至关重要。目前,新药研发主要通过数据分析、生理模型构建等方法获取其药代动力学参数,但结果往往与实际情况有较大差异,且需要更多的人力和物力。
主要探讨机器学习技术在药代动力学参数预测中的应用,这些参数主要涉及药物在人体内吸收、分布、代谢和排泄的定量研究,如生物利用度、清除率、表观分布容积等。
本文首先介绍药代动力学参数、定量构效关系模型与机器学习之间的关系,然后探讨机器学习技术在不同预测模型中的应用,最后讨论机器学习模型在预测药代动力学参数方面的局限性、前景及未来发展。
与传统药代动力学分析不同,机器学习技术能够利用计算机和算法不同程度地加速药代动力学参数的获取。它为加速和缩短药物研发周期提供了新思路,并已成功应用于药物设计与研发。
机器学习技术在预测药代动力学参数方面具有巨大潜力。它也为未来临床药物的设计与研发提供了更多选择和机遇。